Patients Who Have Experienced Treatment Failure At Least Second Line Chemotherapy

1

Review clinical trials related to Patients Who Have Experienced Treatment Failure At Least Second Line Chemotherapy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

This study is a randomized, open-label, multicenter Phase II clinical study, with the objective to assess the efficacy and safety of JMT101 Injection combined with Mitoxantrone Hydrochloride Liposome Injection in patients with recurrent/metastatic nasopharyngeal cancer who have failed at least two prior lines of treatment.

Participants needed: 150
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai JMT-Bio Inc.Updated: Mar 25, 2025
Eligibility criteria

Able to understand and voluntarily sign the written ICF; [+7]

Previously received EGFR monoclonal antibody therapy for recurrent/metastatic na... [+18]